Search Results 631-640 of 25308 for kidney disease
Learn how treatments and lifestyle changes might help reduce kidney damage from this disease.
Tolvaptan is also used to slow kidney function decline in adults who are at risk of rapidly progressing autosomal dominant polycystic kidney disease (ADPKD).
Chebib, M.D., studies autosomal dominant polycystic kidney disease (ADPKD) from multiple points of view: the molecular, translational and epidemiologic levels.
“About 1 in 4 patients had significantly reduced kidney function within two years of being on any of these medications, and 1 in 7 patients had acute kidney ...
Learn about the symptoms, diagnosis and treatments for this type of cancer that begins in the kidney.
Lead author and Mayo Clinic cardiologist Horng Chen, M.B., B.Ch., says, “Kidney-enhancing therapies in acute heart failure continue to elude us. In the past ...
We will determine if living kidney donors are at increased risk of bone disease and fractures following kidney donation. This information will be valuable in ...
A Study to Evaluate the Safety of Lixivaptan in Subjects Previously Treated with Tolvaptan for Autosomal Dominant Polycystic Kidney Disease · Share · Facebook ...
Young children and older adults have a greater risk of developing a life-threatening form of kidney failure. Symptoms. Signs and symptoms of E. coli O157:H7 ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Benefactor support fuels Mayo Clinic’s groundbreaking research. Make a gift today to help us save lives.